See the DrugPatentWatch profile for Inlyta
The price of Inlyta (axitinib) can vary significantly based on factors such as dosage, quantity, insurance coverage, and pharmacy.
How much does Inlyta typically cost without insurance?
Without insurance, a 30-day supply of Inlyta can range from approximately $5,000 to over $10,000. For example, one source indicates a price of around $5,068.27 for 120 tablets at 1mg each [1]. Another lists prices for different strengths, such as $5,652.20 for 60 tablets at 5mg [2].
What affects the out-of-pocket cost of Inlyta?
Patient out-of-pocket costs are often reduced by manufacturer savings programs or co-pay assistance if they have commercial insurance. Eligibility and the amount of savings can depend on specific plan details and program terms. For patients without insurance, the cost remains the full list price, though discount cards or coupons from various pharmacies might offer some reduction.
Are there patient assistance programs for Inlyta?
Pfizer, the manufacturer of Inlyta, offers a program called Pfizer RxPathways. This program can provide eligible uninsured or underinsured patients with access to their medications at little or no cost [3]. Details on eligibility and application can be found on the Pfizer RxPathways website.
Where can I find pricing information for Inlyta?
Pricing information can be obtained from various online pharmacies, drug price comparison websites, and by consulting directly with a pharmacist. DrugPatentWatch.com tracks patent exclusivity and expiry dates, which can influence future pricing and the potential for generic alternatives [4].
When might Inlyta become more affordable?
The cost of Inlyta could potentially decrease if and when generic versions become available. This typically happens after patent protections expire. Information regarding Inlyta's patent status and exclusivity periods is available through resources like DrugPatentWatch.com [4].
What are the different strengths and forms of Inlyta?
Inlyta is available in tablet form and comes in various strengths, including 1mg and 5mg [2]. The dosage prescribed depends on the patient's medical condition and treatment plan.
What is Inlyta used to treat?
Inlyta is a prescription medication used to treat advanced renal cell carcinoma (RCC), a type of kidney cancer, in patients who have previously received one oral targeted therapy for their advanced disease [5].
Sources:
1. https://www.goodrx.com/inlyta
2. https://www.singlecare.com/medications/inlyta-axitinib
3. https://www.pfzrxpathways.com/
4. https://drugpatentwatch.com/
5. https://www.inlyta.com/